8-Hydroxy Quinaldine

8-Hydroxy Quinaldine

SCHEMBL546578

Cc1ccc2cccc([O-])c2n1.Cc1ccc2cccc([O-])c2n1.[Al+2]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.57
CCR1 P32246 1/20 0.56
RAB9A P51151 1/20 0.56
CCR5 P51681 1/20 0.56
PARP1 P09874 1/20 0.49
GLO1 Q04760 2/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP1A2 P05177 1/20 0.43
AGTR1 P30556 1/20 0.41
PAX8 Q06710 1/20 0.41
SLC40A1 Q9NP59 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
BDKRB2 P30411 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
8-Hydroxy Quinaldine SCHEMBL28411833 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL31268359 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL1714541 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL4399934 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL2059590 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL1133461 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL546344 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL1715251 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL1714719 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL28890874 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6423429-B1 None US disclosed
CN-115557996-B Bivalent platinum complex and application thereof as blue phosphorescence material in organic photoelectric device 南京佳诺霖光电科技有限公司 2025-01-21 CN disclosed
CN-119054439-A Organic light emitting device 株式会社LG化学 2024-11-29 CN disclosed
CN-118251377-A Compound for organic electric element, organic electric element using the same, and electronic device using the same 德山新勒克斯有限公司 2024-06-25 CN disclosed
CN-118084810-A Organic electronic element comprising a compound for an organic electronic element and electronic device thereof 德山新勒克斯有限公司 2024-05-28 CN disclosed
CN-118056818-A Compound for organic electronic element, organic electronic element using the same, and electronic device using the same 德山新勒克斯有限公司 2024-05-21 CN disclosed
CN-115703782-B Compound for organic electronic element, organic electronic element using the same, and electronic device using the same 德山新勒克斯有限公司 2024-04-19 CN disclosed
CN-117567443-A Compound for organic electronic element, organic electronic element using the same, and electronic device using the same 德山新勒克斯有限公司 2024-02-20 CN disclosed
CN-117567445-A Compound for organic electronic element, organic electronic element using the same, and electronic device using the same 德山新勒克斯有限公司 2024-02-20 CN disclosed
CN-117377659-A Compound for organic electric element, organic electric element using the same, and electronic device using the same 德山新勒克斯有限公司 2024-01-09 CN disclosed
US-20080100208-A1 ORGANIC LIGHT-EMITTING COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-05-01 US disclosed
US-20080048559-A1 FLUORENE-BASED COMPOUND AND ORGANO-ELECTROLUMINESCENT DEVICE USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-02-28 US disclosed
EP-1892244-A1 Fluorene-based compound and organo-electroluminescent device using the same Samsung Electronics Co., Ltd. (KR) 2008-02-27 EP disclosed
CN-101003545-A Method for preparing hydroxylquinoline aluminium of blue green type mixing ligand TAIYUAN TECH UNIV (CN) 2007-07-25 CN disclosed
EP-1755362-A1 ORGANIC EL DEVICE KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2007-02-21 EP disclosed
US-20060214553-A1 Organic electroluminescent device KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2006-09-28 US disclosed
EP-1613132-A1 ORGANIC ELECTROLUMINESCENT DEVICE Kabushiki Kaisha Toyota Jidoshokki (JP) 2006-01-04 EP disclosed
US-6423429-B2 MADE BY CO-DEPOSITION OR SIMULTANEOUS EVAPORATION OF THE ORGANIC LAYER WITH A COMPOUND CAPABLE OF ACTING AS AN ELECTRON-ACCEPTING DOPANT; REDUCED ENERGY BARRIER IN THE HOLE INJECTION, LOW VOLTAGE CONSUMPTION REGARDLESS WORK FUNCTION Kido, Junji (JP) 2002-07-23 US disclosed
US-20010046611-A1 ORGANIC ELECTROLUMINESCENT DEVICES ROHM CO., LTD. (JP) 2001-11-29 US disclosed
EP-0948063-A2 Organic electroluminescent devices Kido, Junji (JP) 1999-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080048559-A1 FLUORENE-BASED COMPOUND AND ORGANO-ELECTROLUMINESCENT DEVICE USING THE SAME FOXO1, TRPA1, TEC METAP2 3969/4885CCR1 4771/4885RAB9A 2798/4885
US-20080100208-A1 ORGANIC LIGHT-EMITTING COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE C1R, CYBA, LAS1L METAP2 4803/4885CCR1 80/4885RAB9A 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.